LYSANDO AG
14Patents
14Active
14Granted
47Portfolio score
Filing activity: Jun 28, 2010 → May 29, 2019 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8846865B2 | Endolysin OBPgpLYS | Physics | 7 | Active |
| US8906365B2 | Antimicrobial agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US9388400B2 | Composition for use in mycobacteria diagnosis | Chemistry; Metallurgy | 2 | Active |
| US9534223B2 | Method of reducing biofilms | Emerging Cross-Sectional Technologies | 2 | Active |
| US10137175B2 | Antimicrobial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US11958890B2 | Antimicrobial proteins | Chemistry; Metallurgy | 0 | Active |
| US11136570B2 | Antimicrobial fusion proteins comprising an endolysin and an amphipathic peptide segment | Chemistry; Metallurgy | 0 | Active |
| US11427812B2 | Antimicrobial agents against Staphylococcus aureus | Chemistry; Metallurgy | 0 | Active |
| US9169472B2 | Endolysin OBPgpLYS | Physics | 0 | Active |
| US10329550B2 | Antimicrobial agents | Chemistry; Metallurgy | 0 | Active |
| US10184120B2 | Modified KZ144 endolysin sequence | Emerging Cross-Sectional Technologies | 0 | Active |
| US10485854B2 | Method of reducing biofilms | Emerging Cross-Sectional Technologies | 0 | Active |
| US10167462B2 | Modified EL188 endolysin sequence | Human Necessities | 0 | Active |
| US11052137B2 | Antimicrobial agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.